Article Correctness Is Author's Responsibility: Dimethyl Fumarate Therapy Reduces Relapse Rates in Early Multiple Sclerosis

The article below may contain offensive and/or incorrect content.

The ESTEEM study included 3075 patients who were newly prescribed dimethyl fumarate to manage relapsing-remitting multiple sclerosis.